Promus ELITE™
Everolimus-Eluting Platinum Chromium Coronary Stent System
Clinical Outcomes
The Promus ELITE Stent System builds on the proven outcomes of almost 10,000 patients in 11 clinical trials of the PLATINUM family of trials.
PLATINUM Workhorse Trial
Study Objective
Evaluate the safety and effectiveness of the Promus PtCr EES Coronary Stent System* for the treatment of patients with up to 2 de novo lesions ≤ 24 mm in length; ≥ 2.50 mm to ≤ 4.25 mm in diameter compared to the Xience CoCr EES.
Study Design
Prospective, Randomized, Controlled, Non-inferiority, Multicenter
Numerically Lower Ischemia-Driven TLR Through 5 Years2
Numerically Lower Event Rate Through 5 Years2
Outstanding Safety Shown in Real-World Use
Kang Network Meta-Analysis3
SCAAR Registry4
Product Overview
Built to offer outstanding acute performance and proven long-term outcomes.
Deliverability
Enhanced delivery system for the optimal balance of pushability, flexibility and trackability.
Stent Design
Customized stent architecture offers the ideal balance of strength and flexibility.